rofecoxib has been researched along with Acute Kidney Failure in 13 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A patient with acute renal failure associated with lactic acidosis as a result of concurrent treatment with metformin is described." | 7.72 | Metformin lactic acidosis, acute renal failure and rofecoxib. ( Price, G, 2003) |
| " We report a case of reversible acute renal failure due to acute tubulointerstitial nephritis, confirmed by histology of a renal biopsy sample, associated with taking rofecoxib, a selective cyclo-oxygenase-2 (COX-2) inhibitor." | 7.71 | Acute tubulointerstitial nephritis associated with the selective COX-2 enzyme inhibitor, rofecoxib. ( Fernández-Alonso, J; Rocha, JL, 2001) |
| "A patient with acute renal failure associated with lactic acidosis as a result of concurrent treatment with metformin is described." | 3.72 | Metformin lactic acidosis, acute renal failure and rofecoxib. ( Price, G, 2003) |
| " We report a case of reversible acute renal failure due to acute tubulointerstitial nephritis, confirmed by histology of a renal biopsy sample, associated with taking rofecoxib, a selective cyclo-oxygenase-2 (COX-2) inhibitor." | 3.71 | Acute tubulointerstitial nephritis associated with the selective COX-2 enzyme inhibitor, rofecoxib. ( Fernández-Alonso, J; Rocha, JL, 2001) |
| "In the second patient, acute renal failure necessitated hemodialysis." | 2.41 | Nephrotoxicity of selective COX-2 inhibitors. ( Haller, H; Köhler, L; Mengel, M; Schwarz, A; Woywodt, A; Zeidler, H, 2001) |
| "We report a case of reversible acute renal failure due to rofecoxib treatment in an elderly patient with several risk factors associated with traditional nonselective nonsteroidal anti-inflammatory drug (NSAID)-related nephrotoxicity." | 1.31 | Acute renal dysfunction associated with selective COX-2 inhibitor therapy. ( Akritidis, N; Bouropoulos, C; Korantzopoulos, P; Papaioannides, D; Sinapides, D, 2001) |
| " Inhibition of COX-2 has been associated with the therapeutic effects of NSAIDs, whereas inhibition of COX-1 is believed to be the cause of the adverse gastrointestinal effects associated with NSAID therapy." | 1.31 | A comparison of renal-related adverse drug reactions between rofecoxib and celecoxib, based on the World Health Organization/Uppsala Monitoring Centre safety database. ( Arellano, FM; Lejkowith, J; Reynolds, MW; Whelton, A; Zhao, SZ, 2001) |
| "Electrolyte disorders and acute renal failure are observed more frequently in patients with risk factors." | 1.31 | [Renal tolerance of selective inhibitors of cyclooxygenase type 2]. ( Deray, G, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 13 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morales, E | 1 |
| Mucksavage, JJ | 1 |
| Papaioannides, D | 1 |
| Bouropoulos, C | 1 |
| Sinapides, D | 1 |
| Korantzopoulos, P | 1 |
| Akritidis, N | 1 |
| Reinhold, SW | 1 |
| Fischereder, M | 1 |
| Riegger, GA | 1 |
| Krämer, BK | 1 |
| Price, G | 1 |
| Linares, P | 1 |
| Vivas, S | 1 |
| Jorquera, F | 1 |
| Olcoz, JL | 1 |
| de Leon, B | 1 |
| Oritz de Urbina, J | 1 |
| Szalat, A | 1 |
| Krasilnikov, I | 1 |
| Bloch, A | 1 |
| Meir, K | 1 |
| Rubinger, D | 1 |
| Mevorach, D | 1 |
| Fletcher, JT | 1 |
| Graf, N | 1 |
| Scarman, A | 1 |
| Saleh, H | 1 |
| Alexander, SI | 1 |
| Wolf, G | 1 |
| Porth, J | 1 |
| Stahl, RA | 1 |
| Rocha, JL | 1 |
| Fernández-Alonso, J | 1 |
| Wahba, AL | 1 |
| Soper, C | 1 |
| Woywodt, A | 1 |
| Schwarz, A | 1 |
| Mengel, M | 1 |
| Haller, H | 1 |
| Zeidler, H | 1 |
| Köhler, L | 1 |
| Zhao, SZ | 1 |
| Reynolds, MW | 1 |
| Lejkowith, J | 1 |
| Whelton, A | 1 |
| Arellano, FM | 1 |
| Deray, G | 1 |
3 reviews available for rofecoxib and Acute Kidney Failure
| Article | Year |
|---|---|
Cyclooxygenase-2 inhibitor-associated acute renal failure: case report with rofecoxib and review of the literature.
Topics: Acute Kidney Injury; Aged; Clinical Trials as Topic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; | 2002 |
Acute renal failure and interstitial nephritis in a patient treated with rofecoxib: case report and review of the literature.
Topics: Acute Kidney Injury; Adult; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Lactones; Nephr | 2004 |
Nephrotoxicity of selective COX-2 inhibitors.
Topics: Acute Kidney Injury; Adult; Arthritis, Psoriatic; Cyclooxygenase Inhibitors; Follow-Up Studies; Huma | 2001 |
10 other studies available for rofecoxib and Acute Kidney Failure
| Article | Year |
|---|---|
Acute renal dysfunction associated with selective COX-2 inhibitor therapy.
Topics: Acute Kidney Injury; Aged; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; | 2001 |
Acute renal failure after administration of a single dose of a highly selective COX-2 inhibitor.
Topics: Acute Kidney Injury; Aged; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Female; Huma | 2003 |
Metformin lactic acidosis, acute renal failure and rofecoxib.
Topics: Acidosis, Lactic; Acute Kidney Injury; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhib | 2003 |
Severe cholestasis and acute renal failure related to rofecoxib.
Topics: Acute Kidney Injury; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cholestasis; Cyclooxygenase Inhi | 2004 |
Nephrotoxicity with cyclooxygenase 2 inhibitor use in children.
Topics: Acute Kidney Injury; Adolescent; Cyclooxygenase 2 Inhibitors; Female; Humans; Infant; Kidney; Lacton | 2006 |
Acute renal failure associated with rofecoxib.
Topics: Acute Kidney Injury; Contraindications; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Humans; Kidney | 2000 |
Acute tubulointerstitial nephritis associated with the selective COX-2 enzyme inhibitor, rofecoxib.
Topics: Acute Kidney Injury; Aged; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Cyclooxygenase Inhibitor | 2001 |
Acute, anuric renal failure associated with two doses of a cyclooxygenase-2 inhibitor.
Topics: Acute Kidney Injury; Aged; Anuria; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inh | 2001 |
A comparison of renal-related adverse drug reactions between rofecoxib and celecoxib, based on the World Health Organization/Uppsala Monitoring Centre safety database.
Topics: Acute Kidney Injury; Angiotensin Amide; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxy | 2001 |
[Renal tolerance of selective inhibitors of cyclooxygenase type 2].
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Animals; Anti-Inflammatory Agents, Non-Steroida | 2001 |